Download video

August 13, 2022, Revolution Cancer International Molecular Tumor Board (KRAS dismantled, NSCLC)

4.9K views

Revolution Cancer

1 month ago

August 13, 2022, Revolution Cancer International Molecular Tumor Board (KRAS dismantled, NSCLC)

August 13, 2022, Revolution Cancer International Molecular Tumor Board (KRAS dismantled, NSCLC)

Managing Side Effects of New Treatments for Small Cell Lung Cancer
14:57
Managing Side Effects of New Treatments for Small Cell Lung Cancer
by OncBrothers: Practice-Changing Cancer Discussions
Highlights from the IASLC 2022 World Conference on Lung Cancer congress
1:55
Highlights from the IASLC 2022 World Conference on Lung Cancer congress
by VJOncology
Cancer and the Immune System Part 2: Vaccines and Immunotherapy - 2025 Lung Cancer Video Library
5:17
Cancer and the Immune System Part 2: Vaccines and Immunotherapy - 2025 Lung Cancer Video Library
by Global Resource for Advancing Cancer Education
How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos
26:14
How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos
by OncBrothers: Practice-Changing Cancer Discussions
Developments in immunotherapy for lung cancer
1:19
Developments in immunotherapy for lung cancer
by VJOncology
Latest Clinical Data for First-line Maintenance and R\/R Small-Cell Lung Cancer (SCLC)
16:30
Latest Clinical Data for First-line Maintenance and R\/R Small-Cell Lung Cancer (SCLC)
by OncBrothers: Practice-Changing Cancer Discussions
Understanding NSCLC Treatment When You Have an EGFR Mutation
5:03
Understanding NSCLC Treatment When You Have an EGFR Mutation
by You and Lung Cancer
Understanding Non-Small Cell Lung Cancer - updated 2025
5:11
Understanding Non-Small Cell Lung Cancer - updated 2025
by You and Lung Cancer
Immunotherapy Treatments for Small Cell Lung Cancer (SCLC)
2:52
Immunotherapy Treatments for Small Cell Lung Cancer (SCLC)
by You and Lung Cancer
The rationale and trial design of the NADIM II trial
0:48
The rationale and trial design of the NADIM II trial
by VJOncology
IMpower150: Combining VEGF and I-O Therapy in NSCLC
5:47
IMpower150: Combining VEGF and I-O Therapy in NSCLC
by Targeted Oncology
The challenge of treatment resistance in patients with advanced EGFR-mutated NSCLC
1:26
The challenge of treatment resistance in patients with advanced EGFR-mutated NSCLC
by VJOncology
FDA Approval of Datopotamab deruxtecan (Dato-DXd) in EGFR Mutated Lung Cancer - Dr. Jacob Sands
22:23
FDA Approval of Datopotamab deruxtecan (Dato-DXd) in EGFR Mutated Lung Cancer - Dr. Jacob Sands
by OncBrothers: Practice-Changing Cancer Discussions
What is lung cancer staging?
3:13
What is lung cancer staging?
by American Cancer Society
Lung Cancer Living Room - August 16, 2022
1:01:17
Lung Cancer Living Room - August 16, 2022
by GO2 for Lung Cancer
Data on KRAS inhibitors in lung cancer at WCLC 2022
0:35
Data on KRAS inhibitors in lung cancer at WCLC 2022
by VJOncology
Combining radiotherapy with novel agents in NSCLC
0:47
Combining radiotherapy with novel agents in NSCLC
by VJOncology
COAST clinical trial for lung cancer patient
6:08
COAST clinical trial for lung cancer patient
by MedStar Health
Dedicating Our Lives to Lung Cancer
0:16
Dedicating Our Lives to Lung Cancer
by GO2 for Lung Cancer